Syndax Pharmaceuticals - 53 Year Dividend History | SNDX
Historical dividend payout and yield for Syndax Pharmaceuticals (SNDX) since 1971. The current TTM dividend payout for Syndax Pharmaceuticals (SNDX) as of November 01, 2024 is $0.00. The current dividend yield for Syndax Pharmaceuticals as of November 01, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$1.615B |
$0.140B |
|
Syndax Pharmaceuticals, Inc. is a biopharmaceutical company which focused on the development and commercialization of entinostat, an epigenetic therapy for treatment-resistant cancers. The Company's product pipeline includes ENCORE 601, ENCORE 602, J1353, NCI-7870, NCI-9844, E2112, NCI-8871 and NCI-9253 which are in clinical trial stage. Syndax Pharmaceuticals, Inc. is based in WALTHAM, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
